PHAT•benzinga•
Phathom Pharmaceuticals Stock Doubles After FDA Grants Full 10-Year Exclusivity For Voquezna
Summary
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) shares are trading lower Friday after the company announced a major regulatory win.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 6, 2025 by benzinga